Perrigo | PRGO - Pre Tax Profit


Perrigo reported $105.4M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Abbott USD 2.39B 27M Mar/2026
Bayer EUR 2.99B 6.36B Mar/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Corcept Therapeutics USD -44.72M 54.62M Mar/2026
Dr.Reddys Laboratories INR 5.54B 955M Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
J&J USD 8.66B 839M Jun/2026
Merck USD -3.53B 6.95B Mar/2026
Nestle CHF 6.77B 475M Jun/2026
Pacira USD 5M 4.43M Mar/2026
Perrigo USD 105.4M 513.9M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 64.77M 2.96M Mar/2026
Reckitt Benckiser GBP 1.54B 73M Jun/2025
Sanofi EUR 837M 1.17B Jun/2026
Supernus Pharmaceuticals USD -57.65M 51.7M Jun/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zoetis USD 758M 3M Mar/2026